Activated Hypothalamic Pituitary Adrenal Axis in Patients with Metabolic Syndrome

P. Kazakou; V. Kyriazopoulou; M. Michalaki; V. Ierodiakonou; A. Psyrogiannis; I. Habeos

doi:10.1055/s-0032-1311632

Hormone and Metabolic Research, Inhaltsverzeichnis

Horm Metab Res 2012; 44(11): 839-844
DOI: 10.1055/s-0032-1311632

Humans, Clinical

Activated Hypothalamic Pituitary Adrenal Axis in Patients with Metabolic Syndrome

P. Kazakou

¹Endocrine Division, Diabetic Center, Internal Medicine Department, Medical School, University of Patras, Patras, Greece

,

V. Kyriazopoulou

¹Endocrine Division, Diabetic Center, Internal Medicine Department, Medical School, University of Patras, Patras, Greece

,

M. Michalaki

¹Endocrine Division, Diabetic Center, Internal Medicine Department, Medical School, University of Patras, Patras, Greece

,

V. Ierodiakonou

¹Endocrine Division, Diabetic Center, Internal Medicine Department, Medical School, University of Patras, Patras, Greece

,

A. Psyrogiannis

¹Endocrine Division, Diabetic Center, Internal Medicine Department, Medical School, University of Patras, Patras, Greece

,

I. Habeos

¹Endocrine Division, Diabetic Center, Internal Medicine Department, Medical School, University of Patras, Patras, Greece

› Institutsangaben

Abstract

Metabolic syndrome (MetS) is correlated with the activity of hypothalamic-pituitary-adrenal axis (HPA), but the underlying mechanism still remains elusive. The aim of this study was to investigate the HPA axis function in patients with MetS. This case-control study included 159 people. They were divided into 2 groups. The first group included 73 healthy volunteers (control group: 19 males, 54 females, mean±SD: 49.9±7.5 years old, with BMI: 27.9±4.42 kg/m²) and the second group included 86 patients with MetS (case group: 48 males, 38 females, mean±SD: 52.2±7.6 years old, with BMI: 30.5±5.35 kg/m²). An oral glucose tolerance test (OGTT) was performed for all subjects after a 12-h overnight fast, and blood samples were obtained for determination of ACTH, cortisol, insulin, C-peptide, and glucose levels. Serum cortisol after an overnight dexamethasone suppression test was determined in both groups. Patients with MetS had serum cortisol levels after an overnight dexamethasone suppression test significantly higher than controls. During OGTT plasma ACTH levels were higher at all time points in patients with MetS compared to controls, whereas serum cortisol levels were comparable between the 2 groups. Plasma ACTH during OGTT was also correlated with most of the components of MetS. The HPA axis in patients with MetS seems to be more active as evidenced by the higher cortisol levels after the overnight dexamethasone suppression test and by the higher ACTH levels during OGTT. This functional hypercortisolism might be involved in the pathogenesis of the metabolic syndrome.

Key words

ACTH - cortisol - metabolic syndrome - glucocorticoids

Volltext

Referenzen

References
1 Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
2 Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-2701
3 Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738
4 Pasquali R, Biscotti D, Spinucci G, Vicennati V, Genazzani AD, Sgarbi L, Casimirri F. Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution. Clin Endocrinol (Oxf) 1998; 48: 603-612
5 Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 1999; 96: 513-523
6 Dinneen S, Alzaid A, Miles J, Rizza R. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J Clin Invest 1993; 92: 2283-2290
7 Björntorp P, Rosmond R. Hypothalamic origin of the metabolic syndrome X. Ann N Y Acad Sci 1999; 892: 297-307
8 Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000; 24 (Suppl. 02) S50-S55
9 Epel ES, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell KD, Bell J, Ickovics JR. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med 2000; 62: 623-632
10 Chalew S, Nagel H, Shore S. The hypothalamic-pituitary-adrenal axis in obesity. Obes Res 1995; 3: 371-382
11 Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83: 1853-1859
12 Epel EE, Moyer AE, Martin CD, Macary S, Cummings N, Rodin J, Rebuffe-Scrive M. Stress-induced cortisol, mood, and fat distribution in men. Obes Res 1999; 7: 9-15
13 Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. J Endocrinol Invest 2004; 27: 541-547
14 Leal AM, Moreira AC. Food and the circadian activity of the hypothalamic-pituitary-adrenal axis. Braz J Med Biol Res 1997; 30: 1391-1405
15 Korbonits M, Trainer PJ, Nelson ML, Howse I, Kopelman PG, Besser GM, Grossman AB, Svec F. Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution. Clin Endocrinol (Oxf) 1996; 45: 699-706
16 Vicennati V, Ceroni L, Gagliardi L, Gambineri A, Pasquali R. Comment: response of the hypothalamic-pituitary-adrenocortical axis to high-protein/fat and high-carbohydrate meals in women with different obesity phenotypes. J Clin Endocrinol Metab 2002; 87: 3984-3988
17 Obesity: preventing and managing the global epidemic . Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894 (i–xii) 1-253
18 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
19 Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410
20 Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470
21 Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643-1649
22 Nakai Y, Nakaishi S, Kishimoto H, Seino Y, Nagasaka S, Sakai M, Taniguchi A. The threshold value for insulin resistance on homeostasis model assessment of insulin sensitivity. Diabet Med 2002; 19: 346-347
23 Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003; 26: 3320-3325
24 Bergman R, Hücking K, Watanabe R. Measuring insulin action in vivo. Int Textbook Diabetes Mellitus 2004; 16: 303-318
25 Follenius M, Brandenberger G, Hietter B. Diurnal cortisol peaks and their relationships to meals. J Clin Endocrinol Metab 1982; 55: 757-761
26 Gibson EL, Checkley S, Papadopoulos A, Poon L, Daley S, Wardle J. Increased salivary cortisol reliably induced by a protein-rich midday meal. Psychosom Med 1999; 61: 214-224
27 Al-Damluji S, Iveson T, Thomas JM, Pendlebury DJ, Rees LH, Besser GM. Food-induced cortisol secretion is mediated by central alpha-1 adrenoceptor modulation of pituitary ACTH secretion. Clin Endocrinol (Oxf) 1987; 26: 629-636
28 Ishizuka B, Quigley ME, Yen SS. Pituitary hormone release in response to food ingestion: evidence for neuroendocrine signals from gut to brain. J Clin Endocrinol Metab 1983; 57: 1111-1116
29 Reynolds RM, Walker BR, Syddall HE, Whorwood CB, Wood PJ, Phillips DI. Elevated plasma cortisol in glucose-intolerant men: differences in responses to glucose and habituation to venepuncture. J Clin Endocrinol Metab 2001; 86: 1149-1153
30 Reynolds RM, Syddall HE, Walker BR, Wood PJ, Phillips DI. Predicting cardiovascular risk factors from plasma cortisol measured during oral glucose tolerance tests. Metabolism 2003; 52: 524-527
31 Rodman HM, Bleicher SJ. Plasma cortisol during normal glucose tolerance. Metabolism 1973; 22: 745-748
32 Sober AJ, Ruder HJ, Sode J. Adrenal activity during normal glucose tolerance. Acta Endocrinol (Copenh) 1977; 84: 115-118
33 Hautanen A, Adlercreutz H. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J Intern Med 1993; 234: 461-469
34 Cakir M, Sari R, Tosun O, Karayalcin U. Cortisol levels during an oral glucose tolerance test in lean and obese women. Endocr Res 2005; 31: 213-218
35 Fernández-Real JM, Ricart W, Casamitjana R. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity. Clin Endocrinol (Oxf) 1997; 47: 583-588
36 Beuschlein F, Borgemeister M, Schirra J, Göke B, Fassnacht M, Arlt W, Allolio B, Reincke M. Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas. Clin Endocrinol (Oxf) 2000; 52: 617-623
37 Ljung T, Andersson B, Bengtsson BA, Björntorp P, Marin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes Res 1996; 4: 277-282
38 Duclos M, Gatta B, Corcuff JB, Rashedi M, Pehourcq F, Roger P. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids. Clin Endocrinol (Oxf) 2001; 55: 447-454
39 Pasquali R, Ambrosi B, Armanini D, Cavagnini F, Uberti ED, Del Rio G, de Pergola G, Maccario M, Mantero F, Marugo M, Rotella CM, Vettor R. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. J Clin Endocrinol Metab 2002; 87: 166-175
40 Duclos M, Marquez Pereira P, Barat P, Gatta B, Roger P. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res 2005; 13: 1157-1166
41 Fruehwald-Schultes B, Kern W, Born J, Fehm HL, Peters A. Hyperinsulinemia causes activation of the hypothalamus-pituitary-adrenal axis in humans. Int J Obes Relat Metab Disord 2001; 25 (Suppl. 01) S38-S40